Has Donna Culton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $106,250 in general payments to Donna Culton, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Donna Culton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Donna Culton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Donna Culton, MD

Dermatology · Chapel Hill, NCNPI 1487876223

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,398 of the $106,250 with a category attached, or 63.4%. 11 manufacturers reported payments, led by Regeneron at 34.8% of the total. 2025 is the largest year on record at $48,163, more than ten times the $1,800 reported in 2021. Among dermatology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$106,250in general payments, 2019–2025

Across 85 payments — averaging $1250.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$37K
Sanofi$29K
Argenx US, Inc.$22K
Regeneron Healthcare Solutions, Inc.$14K
Janssen Global Services, LLC$2K
Grifols, S.A.$2K
plus $308 from 5 others

$386,858in research payments, 2019–2025

Across 106 payments — averaging $3649.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$82K
Incyte Corporation$69K
Lilly USA, LLC$69K
Pfizer$58K
Principia Biopharma Inc.$55K
GSK$21K
plus $32K from 2 others

What the payments were for

Consulting fees$67,39863%
Speaking & faculty fees$32,76531%
Travel & lodging$4,3234%
Food & beverage$1,7642%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	39	$36,979
Sanofi	14	$28,691
Argenx US, Inc.	13	$22,287
Regeneron Healthcare Solutions, Inc.	8	$14,166
Janssen Global Services, LLC	1	$2,020
Grifols, S.A.	3	$1,800
Johnson & Johnson	1	$118
Journey Medical Corporation	2	$85
LEO Pharma Inc.	2	$71
Takeda Pharmaceuticals U.S.A., Inc.	1	$31
Pfizer	1	$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$50,259
VYVGART$16,094
Tremfya$118

How this compares

$106,250 in reported general payments places this provider in the 95th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$96,722

Medicare patients

372

Services billed

1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	17	$84,572
Metronidazole	35	$6,143
Dapsone	31	$3,772
Mycophenolate Mofetil	30	$3,509
MethotrexateMethotrexate Sodium	80	$2,108
Hydroxychloroquine Sulfate	51	$1,543
Clobetasol Propionate	32	$1,152
ValacyclovirValacyclovir Hcl	14	$640
Clotrimazole	15	$632
Dexamethasone	12	$429
Prednisone	61	$410
Fluconazole	18	$266
Folic Acid	13	$115
Triamcinolone Acetonide	14	$102

Paid to pharmacies, not to this prescriber.

Other dermatology in Chapel Hill

Christopher SayedChapel Hill$690K
Sue Ellen CoxChapel Hill$180K
Chris AdigunChapel Hill$71K
Priyanka VedakChapel Hill$25K
David DevriesChapel Hill$17K
David RubensteinChapel Hill$16K
Steven FeldmanWinston Salem$3.4M
Nicole SeminaraHuntersville$1.4M
Andrew LeeElkin$702K
William HooverConcord$594K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →